Innovative trifocal (quadrifocal) presbyopia-correcting IOLs: 1-year outcomes from an international multicenter study

PURPOSE: To evaluate visual acuity (VA) and safety of the new AcrySof IQ PanOptix presbyopia-correcting IOL at 12 months postimplantation. SETTING: Seventeen sites in Europe, Australia, and South America. DESIGN: Prospective, single-arm, nonmasked, nonrandomized study. METHODS: Of 167 patients enrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohnen, Thomas, Marchini, Giorgio, Alfonso, Jose F., Bala, Chandra, Cochener, Beatrice, Martinez, Aldo, Carreño, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688079/
https://www.ncbi.nlm.nih.gov/pubmed/32358415
http://dx.doi.org/10.1097/j.jcrs.0000000000000232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688079/
https://www.ncbi.nlm.nih.gov/pubmed/32358415
http://dx.doi.org/10.1097/j.jcrs.0000000000000232

Ejemplares similares